» Articles » PMID: 9529052

Immune Responses of Specific-pathogen-free Mice to Chronic Helicobacter Pylori (strain SS1) Infection

Overview
Journal Infect Immun
Date 1998 Apr 7
PMID 9529052
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

A model permitting the establishment of persistent Helicobacter pylori infection in mice was recently described. To evaluate murine immune responses to H. pylori infection, specific-pathogen-free Swiss mice (n = 50) were intragastrically inoculated with 1.2 x 10(7) CFU of a mouse-adapted H. pylori isolate (strain SS1). Control animals (n = 10) received sterile broth medium alone. Animals were sacrificed at various times, from 3 days to 16 weeks postinoculation (p.i.). Quantitative culture of gastric tissue samples from inoculated mice demonstrated bacterial loads of 4.0 x 10(4) to 8 x 10(6) CFU per g of tissue in the animals. Infected mice had H. pylori-specific immunoglobulin M (IgM) and IgG antibodies in serum (at day 3 p.i.) and IgG and IgA antibodies in their gastric contents (weeks 4 and 16 p.i.) and saliva (week 16 p.i.). Mucosal IgM antibodies were not detected. Histological examination of the gastric mucosae from control and infected mice revealed mild chronic gastritis, characterized by the presence of polymorphoneutrophil cell infiltrates and submucosal lymphoid aggregates, in infected animals at 16 weeks p.i. Differences in the quantities of IgG1 and IgG2a subclass antibodies detected in the sera of mouse strains (Swiss, BALB/c, and C57BL/6) infected by H. pylori suggested that host factors influence the immune responses induced against this bacterium in the host. In conclusion, immune responses to H. pylori infection in mice, like those in chronically infected humans, appear to be ineffective in resolving the infection.

Citing Articles

Solid Lipid Nanoparticles Delivering a DNA Vaccine Encoding Urease A Subunit: Immune Analyses before and after a Mouse Model of Infection.

Francis J, Skakic I, Majumdar D, Taki A, Shukla R, Walduck A Int J Mol Sci. 2024; 25(2).

PMID: 38256149 PMC: 10816323. DOI: 10.3390/ijms25021076.


Sustain-release lipid-liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL/6 mice.

Ghazvini K, Kamali H, Farsiani H, Yousefi M, Keikha M BMC Pharmacol Toxicol. 2024; 25(1):9.

PMID: 38212864 PMC: 10785446. DOI: 10.1186/s40360-024-00731-z.


An Evaluation of Urease A Subunit Nanocapsules as a Vaccine in a Mouse Model of Infection.

Skakic I, Francis J, Dekiwadia C, Aibinu I, Huq M, Taki A Vaccines (Basel). 2023; 11(11).

PMID: 38005984 PMC: 10674275. DOI: 10.3390/vaccines11111652.


Animal Models and Infection.

Ansari S, Yamaoka Y J Clin Med. 2022; 11(11).

PMID: 35683528 PMC: 9181647. DOI: 10.3390/jcm11113141.


MicroRNA (miR) dysregulation during -induced gastric inflammation and cancer development: critical importance of miR-155.

Prinz C, Weber D Oncotarget. 2020; 11(10):894-904.

PMID: 32206186 PMC: 7075464. DOI: 10.18632/oncotarget.27520.


References
1.
Mitchell J, Mitchell H, Tobias V . Acute Helicobacter pylori infection in an infant, associated with gastric ulceration and serological evidence of intra-familial transmission. Am J Gastroenterol. 1992; 87(3):382-6. View

2.
Sobala G, Crabtree J, Dixon M, Schorah C, Taylor J, Rathbone B . Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut. 1991; 32(11):1415-8. PMC: 1379180. DOI: 10.1136/gut.32.11.1415. View

3.
Crabtree J, Wyatt J, Sobala G, Miller G, Tompkins D, Primrose J . Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993; 34(10):1339-43. PMC: 1374537. DOI: 10.1136/gut.34.10.1339. View

4.
Crabtree J, Wyatt J, Trejdosiewicz L, Peichl P, Nichols P, Ramsay N . Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994; 47(1):61-6. PMC: 501759. DOI: 10.1136/jcp.47.1.61. View

5.
Ferrero R, Thiberge J, Huerre M, Labigne A . Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun. 1994; 62(11):4981-9. PMC: 303216. DOI: 10.1128/iai.62.11.4981-4989.1994. View